Omega Healthcare Investors IncOmega raised full-year AFFO guidance, reported strong earnings, and increased dividend, all positive financial events.

Omega Healthcare Investors reported second-quarter 2026 net income of $380 million, or $1.19 per diluted share, and raised its full-year adjusted funds from operations guidance to a range of $3.22 to $3.26 per share. The company completed $126 million in new investments during the quarter, including $110 million in real estate acquisitions and $16 million in real estate loan fundings, and increased its quarterly dividend by one cent to $0.68 per share. Omega also sold 26 facilities for $563 million, recognizing a gain of $246.5 million, and received $172 million in loan repayments. CEO Taylor Pickett noted that the favorable operating backdrop and strong pipeline position the company for outsized shareholder returns.
Omega Healthcare Investors IncOmega raised full-year AFFO guidance, reported strong earnings, and increased dividend, all positive financial events.